Man Group PLC Cytom X Therapeutics, Inc. Transaction History

Man Group PLC

$38.1 Billion
Q1 2024

A detailed history of Man Group PLC transactions in Cytom X Therapeutics, Inc. stock. As of the latest transaction made, Man Group PLC holds 191,060 shares of CTMX stock, worth $324,802. This represents 0.0% of its overall portfolio holdings.

Number of Shares

191,060

Holding current value

$324,802

% of portfolio

0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$1.41 - $2.74 $269,394 - $523,504	191,060 New	191,060 $416,000
Q1 2023 May 15, 2023	BUY	$1.48 - $2.88 $23,273 - $45,288	15,725 Added 45.48%	50,300 $75,000
Q4 2022 Feb 14, 2023	BUY	$1.19 - $1.91 $10,882 - $17,466	9,145 Added 35.96%	34,575 $55,000
Q3 2022 Nov 14, 2022	SELL	$1.23 - $1.97 $14,847 - $23,779	-12,071 Reduced 32.19%	25,430 $36,000
Q2 2022 Aug 15, 2022	BUY	$1.53 - $2.89 $57,376 - $108,377	37,501 New	37,501 $68,000

Q2 2021 Aug 16, 2021	SELL	$6.33 - $9.91 $291,104 - $455,741	-45,988 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$6.6 - $9.0 $1.46 Million - $1.99 Million	-220,998 Reduced 82.78%	45,988 $355,000
Q4 2020 Feb 16, 2021	BUY	$6.47 - $7.9 $292,275 - $356,874	45,174 Added 20.37%	266,986 $1.75 Million
Q3 2020 Nov 16, 2020	BUY	$6.55 - $8.83 $179,470 - $241,942	27,400 Added 14.09%	221,812 $1.48 Million
Q2 2020 Aug 14, 2020	SELL	$7.4 - $14.64 $577,185 - $1.14 Million	-77,998 Reduced 28.63%	194,412 $1.62 Million
Q1 2020 May 15, 2020	SELL	$3.61 - $8.6 $174,164 - $414,907	-48,245 Reduced 15.05%	272,410 $2.09 Million
Q4 2019 Feb 18, 2020	BUY	$5.17 - $8.91 $1.6 Million - $2.76 Million	310,309 Added 2999.31%	320,655 $2.67 Million
Q3 2019 Nov 14, 2019	BUY	$7.38 - $12.25 $76,353 - $126,738	10,346 New	10,346 $76,000
Q2 2019 Aug 14, 2019	SELL	$9.35 - $11.41 $764,811 - $933,315	-81,798 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$9.5 - $19.16 $526,898 - $1.06 Million	-55,463 Reduced 40.41%	81,798 $879,000
Q4 2018 Feb 14, 2019	SELL	$12.69 - $18.61 $493,628 - $723,910	-38,899 Reduced 22.08%	137,261 $2.07 Million
Q3 2018 Nov 14, 2018	SELL	$18.04 - $26.41 $3.35 Million - $4.9 Million	-185,590 Reduced 51.3%	176,160 $3.26 Million
Q2 2018 Aug 14, 2018	SELL	$21.38 - $29.68 $977,771 - $1.36 Million	-45,733 Reduced 11.22%	361,750 $8.27 Million
Q1 2018 May 15, 2018	BUY	$21.76 - $34.22 $8.87 Million - $13.9 Million	407,483 New	407,483 $11.6 Million

Others Institutions Holding CTMX

# of Institutions

Shares Held

43.9M

Call Options Held

105K

Put Options Held

4.5K

Bvf Inc San Francisco, CA

6.6M
Shares

$11.2 Million
0.43% of portfolio
Tang Capital Management LLC San Diego, CA

6.45M
Shares

$11 Million
1.71% of portfolio
Vanguard Group Inc Valley Forge, PA

4.86M
Shares

$8.26 Million
0.0% of portfolio
Orbimed Advisors LLC San Diego, CA

3.54M
Shares

$6.03 Million
0.17% of portfolio
Acadian Asset Management LLC Boston, MA

2.69M
Shares

$4.57 Million
0.02% of portfolio

View Full List

About CytomX Therapeutics, Inc.

Ticker CTMX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,950,200
Market Cap $112M
Description
CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical...

More about CTMX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Man Group PLC with notifications on news.

Account